Synthesis of Allopumiliotoxins
J. Am. Chem. Soc., Vol. 118, No. 38, 1996 9081
91.4 (s), 86.6 (d), 82.3 (s), 79.4 (s), 69.6 (t), 66.8 (d), 66.5 (t), 66.3
(d), 54.9 (t), 44.0 (t), 34.5 (t), 27.8 (t), 26.4 (t), 26.3 (d), 24.1 (t), 20.3
MHz, CDCl3) δ 7.34-7.20 (m, 10H), 5.37-5.28 (m, 3H), 4.57 (ABq,
J ) 12.8 Hz, ∆ν ) 8.3 Hz, 2H), 4.36 (ABq, J ) 11.9 Hz, ∆ν ) 60.9
Hz, 2H), 4.07 (s, 1H), 3.72 (d, J ) 13.3 Hz, 1H), 3.55 (t, J ) 7.0 Hz,
1H), 3.12 (t, J ) 8.2 Hz, 1H), 2.75 (d, J ) 12.2 Hz, 1H), 2.62-2.40
(m, 2H), 1.58 (s, 3H), 1.26 (s, 3H), 1.04 (d, J ) 6.5Hz, 3H), 0.84 (t,
J ) 7.4 Hz, 3H); 13C NMR (75 MHz, CDCl3) 140.2, 138.9, 136.0,
135.4, 134.1, 128.2, 128.0, 127.7, 127.3, 127.2, 126.9, 126.9, 86.8,
76.5, 75.9, 69.6, 66.3, 64.5, 54.3, 48.5, 35.4, 32.2, 26.2, 22.8, 20.9,
20.5, 18.7, 10.9, 10.4 ppm; MS (CI, isobutane) m/e 504 (MH), 396,
380, 288, 272, 107, 91; HRMS (EI) m/e 412.2845 (412.2852 calcd for
C26H38NO3, M - PhCH2).
(q), 14.9 (q), 10.8 (q), 10.3 (q) ppm; IR (film) 3606-3250, 2244 cm-1
;
MS (CI, isobutane) m/e 529 (MH), 502; HRMS (EI) m/e 528.3346
(528.3352 calcd for C34H44N2O3).
Minor anti diastereomer 41: 1H NMR (500 MHz, CDCl3) δ 7.27-
7.38 (m, 10H), 5.44 (t, J ) 7.1 Hz, 1H), 4.20-4.65 (m, 6H), 3.06 (m,
1H, 2H), 2.71 (m, 1H), 2.62 (m, 1H), 2.30 (m, 2H), 1.48-2.10 (m,
6H), 1.63 (s, 3H), 1.25 (d, J ) 7.0 Hz, 3H), 1.24 (s, 3H), 0.86 (t, J )
7.5 Hz, 3H).
(7R,8R,8aS)-8-(Benzyloxy)-7-[(3R,5E,7S)-7-(benzyloxy)-3,6-di-
methyl-5-decen-1-ynyl]-8-methyl-6-oxaoctahydroindolizidine (42).
A solution of alcohol 40 (60 mg, 0.11 mmol), Cu(OTf)2 (82 mg, 0.23
mmol), and dry THF (3 mL) was stirred at room temperature. A gray
precipitate formed slowly over a 19 h period. The reaction then was
quenched by the addition of saturated aqueous NaHCO3 (20 mL), and
the resulting mixture was extracted with EtOAc (100 mL). The organic
layer was washed with saturated aqueous NaHCO3 (20 mL), dried (K2-
CO3), and concentrated. Purification of the residue by radial chroma-
tography on silica gel (1 mm plate, 2:1 hexane-EtOAc) gave 38 mg
(+)-Allopumiliotoxin 323 B′ (4). A solution of 44 (15 mg, 0.030
mmol), THF (1.0 mL), and NH3 (5 mL, freshly distilled) was cooled
to -78 °C and treated with excess Li until the blue color persisted for
2 min. The reaction was then quenched by the addition of solid NH4-
Cl. This mixture was allowed to warm to room temperature and then
was diluted with 1 M aqueous Na2CO3 (10 mL) and extracted with
CHCl3 (3 × 15 mL). After drying (K2CO3) and concentration, the
residue was purified on silica gel (15:1:0.1 CHCl3-MeOH-NH4OH)
to give 6.5 mg (86%) of 4 as a colorless oil: [R]23D +23.8, [R]577 +19.8,
[R]546 +25.0, [R]435 +52.9, [R]405 +66.2 (c 0.42 CHCl3). Synthetic 4
(68%) of 42 as a clear oil: [R]23 -89.0, [R]577 -93.5, [R]546 -106,
D
1
showed TLC mobility and 250 MHz H NMR, 125 MHz 13C NMR,
[R]435 -181, [R]405 -217 (c 2.1, CHCl3); IR (film) 2237 cm-1; 1H NMR
(500 MHz, CDCl3) δ 7.23-7.39 (m, 10H), 5.41 (m, 1H), 5.01 (ABq,
J ) 11.6 Hz, ∆ν ) 198.1 Hz, 2H), 4.54 (ABq, J ) 10.0 Hz, ∆ν )
197.2 Hz, 2H), 4.34 (ABq, J ) 11.9 Hz, ∆ν ) 130.3 Hz, 2H), 4.07 (br
s, 1H), 3.53 (t, J ) 6.9 Hz, 1H), 3.42 (m, 1H), 2.72 (m, 1H), 2.55-
2.65 (m, 2H), 2.3 (m, 2H), 1.48-2.01 (m, 6H), 1.58 (s, 3H), 1.25 (s,
3H), 1.17 (d, J ) 6.9 Hz, 3H), 0.83 (t, J ) 7.5 Hz, 3H); 13C NMR
(125 MHz, CDCl3) 140.1 (s), 139.0 (s), 136.2 (s), 128.2 (d), 128.0 (d),
127.6 (d), 127.2 (d), 127.0 (d), 126.8 (d), 126.1 (d), 92.0 (s), 86,6 (d),
81.8 (t), 76.6 (s), 74.9 (d), 74.5 (s), 69.5 (t), 67.3 (d), 67.2 (d), 49.4 (t),
34.5 (t), 26.4 (t), 26.3 (d), 25.2 (t), 22.8 (t), 20.1 (q), 18.5 (q), 10.7 (q),
10.3 (q) ppm; MS (CI, isobutane) m/e 502 (MH), 394; HRMS (EI)
m/e 410.2682 (410.2695 calcd for C26H36NO3 M - PhCH2).
and mass spectra that were indistinguishable from those of a natural
specimen.
(S)-2-[(1R,2R,5R,7E,9R,10R)-1-(Benzyloxy)-2-hydroxy-9,10-O-iso-
propylidene-1,5,8-trimethyl-7-undecen-3-ynyl]-1-(cyanomethyl)pyr-
rolidine (46). Following the procedure described for preparation of
40, a solution of the alkyne 45 (150 mg, 0.68 mmol) and THF (1.4
mL) was treated with n-BuLi (300 µL, 2.2 M in hexanes, 0.66 mmol)
at -15 °C. The resulting dark anion solution was maintained at -15
°C for 15 min and then cooled to -78 °C. A solution of aldehyde 20
(140 mg, 0.51 mmol) and THF (1.6 mL) was added dropwise, and the
resulting solution was maintained at -78 °C for 2.5 h. Workup
provided a dark oil that was purified on silica gel (8:1 hexane-EtOAc)
to give 43 mg (17%) of the anti diastereomer 47 and 172 mg (68%) of
the syn isomer 46. Also isolated were recovered alkyne 45 (51 mg,
34%) and aldehyde 20 (21 mg, 15%). Characterization data for 46:
[R]22D -73.6, [R]577 -73.5, [R]546 -79.4, [R]435 -118 (c 0.9, CHCl3);
(7R,8R,8aS)-8-(Benzyloxy)-7-hydroxy-8-methyl-6-(Z)-[(2R,4E,6S)-
6-(benzyloxy)-2,5-dimethyl-1-iodo-4-octenylidene]octahydroindoliz-
idine (43). A solution of 41 (88 mg, 0.18 mmol), camphorsulphonic
acid (44 mg, 0.18 mmol), paraformaldehyde (11 mg, 0.35 mmol), NaI
(260 mg, 1.8 mmol), and H2O (4.5 mL) was heated in a sealed vial at
100 °C for 1 h. The resulting mixture was allowed to cool to room
temperature and then was partitioned between CH2Cl2 (50 mL) and 1
M NaHCO3 (30 mL). The aqueous layer was extracted with CH2Cl2
(20 mL), and the combined organic layers were dried (K2CO3) and
concentrated. Purification of the residue on silica gel (50:1:0.1 CHCl3-
MeOH-NH4OH) gave 73 mg (66%) of 43 as a colorless oil that was
homogeneous by TLC analysis (high Rf) and 15 mg (14%) of the C(11)
epimer (low Rf). Characterization data for 43: IR (film) 3387, 2968,
1
IR (film) 3463, 2982, 2250, 1455, 1379, 1239, 1103, 1036 cm-1; H
NMR (300 MHz, CDCl3) δ 7.40-7.25 (m, ArH, 5H), 5.57 (dt, J )
7.1, 0.9 Hz, 1H), 4.82 (ABq, JAB ) 10.9 Hz, ∆νAB ) 98.3, 2H), 4.31
(br d, J ) 4.9 Hz, 1H), 3.86 (m, 2H), 3.73 (ABq, JAB ) 17.2 Hz, ∆νAB
) 74.4 Hz, 2H), 3.18 (dd, J ) 8.9, 5.1 Hz, 1H), 3.07 (dt, J ) 3.7, 5.7
Hz, 1H), 2.99 (br d, J ) 7.3 Hz, OH, 1H), 2.69 (m, 1H), 2.59 (dq, J
) 7.0, 1.7 Hz, 1H), 2.25 (m, 2H), 1.97 (m, 2H), 1.83-1.68 (m, 2H),
1.65 (s, 3H), 1.42 (s, 3H), 1.41 (s, 3H), 1.40 (s, 3H), 1.20 (d, J ) 4.5
Hz, 3H), 1.18 (d, J ) 6.9 Hz, 3H); 13C NMR (75.5 MHz, CDCl3) 138.6,
132.9, 128.4, 127.5, 127.0, 116.7, 107.9, 91.1, 88.4, 82.3, 79.6, 74.2,
66.8, 66.5, 66.2, 54.8, 43.9, 34.6, 27.8, 27.4, 26.8, 26.0, 24.0, 20.2,
16.9, 14.9, 11.7 ppm; MS (CI, isobutane) m/e 495 (MH), 468, 437,
410, 304, 246; HRMS (CI) m/e 495.3225 (495.3223 calcd for
C30H43N2O4, MH).
1
2931, 2875, 1456, 1056, 912 cm-1; H NMR (300 MHz, CDCl3) δ
7.25-7.09 (m, 10H), 5.13 (bt, J ) 7.3 Hz, 1H), 4.75 (br s, 1H), 4.51
(ABq, J ) 12.2 Hz, ∆ν ) 14.4 Hz, 2H), 4.25 (ABq, J ) 11.8 Hz, ∆ν
) 64.9 Hz, 2H), 3.90 (d, J ) 12.8 Hz, 1H), 3.43 (t, J ) 6.9 Hz, 1H),
2.98 (br t, J ) 7.0 Hz, 1H), 2.80 (d, J ) 12.8 Hz, 1H), 2.45-2.29 (m,
2H), 2.17-1.33 (m, 8H), 1.53 (s, 3H), 1.16 (s, 3H), 0.97 (d, J ) 6.3
Hz, 3H), 0.74 (t, J ) 7.4 Hz, 3H); 13C NMR (75 MHz, CDCl3) 140.0,
138.9, 138.5, 136.1, 128.2, 128.0, 127.7, 127.3, 127.1, 126.9, 125.6,
121.9, 86.6, 80.8, 76.8, 69.7, 66.1, 65.5, 53.4, 50.8, 39.2, 35.4, 26.3,
22.8, 22.4, 21.2, 18.9, 11.2, 10.3 ppm; MS (CI, isobutane) m/e 630
(MH), 522, 502, 410, 396, 364, 300, 147, 107, 91; HRMS (EI) m/e
538.1806 (538.1818 calcd for C26H37NO3I, M - PhCH2).
Diastereomer 47: [R]22 -20.8, [R]577 -24.7, [R]546 -25.6, [R]435
D
-32.4 (c 2.0, CHCl3); IR (film) 3438, 3294, 2982, 2250, 1455, 1380,
1239, 1038 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.40-7.25 (m, ArH,
5H), 5.94 (br s, OH, 1H), 5.59 (t, J ) 7.2 Hz, 1H), 4.65 (d, J ) 1.2
Hz, 1H), 4.53 (ABq, JAB ) 10.8 Hz, ∆νAB ) 52.9 Hz, 2H), 3.92 (ABq,
JAB ) 17.3 Hz, ∆νAB ) 204.9 Hz, 2H), 3.88 (m, 2H), 3.54 (dd, J )
8.3, 4.4 Hz, 1H), 3.15 (m, 1H), 2.77 (dt, J ) 10.2, 7.0 Hz, 1H), 2.61
(dq, J ) 6.9, 1.6 Hz, 1H), 2.27 (m, 2H), 2.05 (m, 2H), 1.90 (m, 2H),
1.68 (s, 3H), 1.42 (s, 6H), 1.26 (s, 3H), 1.23 (d, J ) 5.5 Hz, 3H), 1.21
(d, J ) 6.9 Hz, 3H); 13C NMR (75.5 MHz, CDCl3) δ 138.9, 133.0,
128.3, 128.1, 127.4, 127.1, 127.0, 117.1, 107.9, 91.5, 88.3, 80.3, 79.1,
74.3, 69.5, 66.7, 63.7, 55.1, 44.4, 34.7, 27.4, 27.0, 26.8, 26.0, 24.9,
20.3, 18.6, 17.0, 11.6 ppm; MS (CI, isobutane) m/e 495, 468, 437,
410, 304; HRMS (CI) m/e 495.3223 (495.3223 calcd for C30H43N2O4
(MH).
(7R,8R,8aS)-8-(Benzyloxy)-7-hydroxy-8-methyl-6-(E)-[(2R,4E,6S)-
6-(benzyloxy)-2,5-dimethyl-4-octenylidine]octahydroindolizidine (44).
A hexane solution of n-BuLi (0.28 mL, 2.05 M, 0.58 mmol) was added
dropwise to a solution of 43 (66 mg, 0.11 mmol) and dry THF (4.0
mL) at -78 °C. This solution was maintained at -78 °C for 1 h and
MeOH (100 mL) was added. The resulting solution was allowed to
warm to room temperature and then was partitioned between CHCl3
(50 mL) and brine (30 mL). The organic layer was separated, dried
(K2CO3), and concentrated. Purification of the residue on silica gel
(50:1:0.1 CHCl3-MeOH-NH4OH) gave 44 mg (83%) of 44 as a
(7R,8R,8aS)-8-(Benzyloxy)-7-[(3R,5E,7R,8R)-3,6-dimethyl-7,8-O-
isopropylidene-5-decen-1-ynyl]-8-methyl-6-oxaoctahydroindolizi-
dine (48). Silver triflate (25 mg, 0.097 mmol) was added in one portion
to a solution of the alcohol 46 (20 mg, 0.041 mmol) and THF (1.5
mL) at room temperature. The reaction was protected from light and
colorless oil that was homogeneous by TLC analysis: [R]23 +2.5,
D
[R]577 +5.6, [R]546 +5.4, [R]435 +10.6, [R]405 +14.1 (c 1.1 CHCl3); IR
1
(film) 3431, 2962, 1456, 1093, 1056, 750, 700 cm-1; H NMR (300